Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Neuer optischer Verstärker für KI-Rechenzentren treibt Aeva-Aktie an (Investing.com DE) +++ AEVA Aktie +3,19%

ZOETIS Aktie

 >ZOETIS Aktienkurs 
108.98 EUR    +0.9%    (Tradegate)
Ask: 108.94 EUR / 93 Stück
Bid: 108.8 EUR / 28 Stück
Tagesumsatz: 1316 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ZOETIS Aktie über LYNX handeln
>ZOETIS Performance
1 Woche: -0,3%
1 Monat: +6,4%
3 Monate: -12,2%
6 Monate: -19,6%
1 Jahr: -32,6%
laufendes Jahr: +0,3%
>ZOETIS Aktie
Name:  ZOETIS INC. CL.A DL -,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98978V1035 / A1KBYX
Symbol/ Ticker:  ZOE (Frankfurt) / ZTS (NYSE)
Kürzel:  FRA:ZOE, ETR:ZOE, ZOE:GR, NYSE:ZTS
Index:  S&P500
Webseite:  https://www.zoetis.com/
Profil:  Zoetis Inc. is a global leader in the animal healt..
>Volltext..
Marktkapitalisierung:  47424.66 Mio. EUR
Unternehmenswert:  51854.08 Mio. EUR
Umsatz:  8069.32 Mio. EUR
EBITDA:  3456.32 Mio. EUR
Nettogewinn:  2276.45 Mio. EUR
Gewinn je Aktie:  5.1 EUR
Schulden:  6245.41 Mio. EUR
Liquide Mittel:  1789.56 Mio. EUR
Operativer Cashflow:  2504 Mio. EUR
Bargeldquote:  1.15
Umsatzwachstum:  -2.58%
Gewinnwachstum:  3.51%
Dividende je Aktie:  1.72 EUR
Dividendenrendite:  1.6%
Dividendenschätzung:  1.69%
Div. Historie:  31.10.25 - 0.4319€
18.07.25 - 0.429€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ZOETIS, ZÖTIS
Letzte Datenerhebung:  15.01.26
>ZOETIS Kennzahlen
Aktien/ Unternehmen:
Aktien: 440.69 Mio. St.
Frei handelbar: 99.82%
Rückkaufquote: 3.13%
Mitarbeiter: 13800
Umsatz/Mitarb.: 0.58 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 27.29%
Bewertung:
KGV: 21.07
KGV lG: 19.75
KUV: 5.9
KBV: 10.23
PEG-Ratio: 1.82
EV/EBITDA: 15
Rentabilität:
Bruttomarge: 70.29%
Gewinnmarge: 28.21%
Operative Marge: 37.63%
Managementeffizenz:
Gesamtkaprendite: 17.96%
Eigenkaprendite: 49.87%
>ZOETIS Peer Group

Es sind 592 Aktien bekannt.
 
13.01.26 - 01:48
Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)
 
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...
13.01.26 - 01:45
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts (Zacks)
 
Zoetis (ZTS) reached $125.32 at the closing of the latest trading day, reflecting a -1.45% change compared to its last close....
12.01.26 - 22:54
Zoetis CEO on Animal Health, Vaccines and Beef Prices (Bloomberg)
 
Zoetis CEO Kristin Peck says higher protein demand is driving demand for livestock vaccines. She speaks with Katie Greifeld at JPMorgan's annual health-care conference in San Francisco. (Source: Bloomberg)...
30.12.25 - 14:36
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
 
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2025 financial results and respond to questions from financial analysts. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. Pre-registration for the webcast is available beginning today. A replay of the webcast will be made available on February 12, 2026. About Zoetis As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinari...
23.12.25 - 01:45
Zoetis (ZTS) Outperforms Broader Market: What You Need to Know (Zacks)
 
Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day....
16.12.25 - 09:18
Zoetis prices $1.75 billion convertible senior notes (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.12.25 - 07:18
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering (Business Wire)
 
Substantially All of Net Proceeds Expected to Be Used to Repurchase Approximately $1.6 Billion of Common Stock and for Capped Call Transactions PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis has also granted the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $250 million aggregate principal amount of Notes. The offering is expected to close on December 18, 2025, subject to the satisfaction of customary closing conditions. Use of Proceeds – Sh...
15.12.25 - 15:18
Animal Health Firm Zoetis Offers $1.75 Billion Convertible Bond (Bloomberg)
 
Zoetis Inc., an animal medicine company, is seeking to raise $1.75 billion in a convertible bond sale....
15.12.25 - 13:12
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering (Business Wire)
 
Substantially All Net Proceeds Expected to Be Used to Repurchase Common Stock and for Capped Call Transactions PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market conditions, it intends to offer $1.75 billion aggregate principal amount of convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $250 million aggregate principal amount of Notes. Zoetis intends to use the net proceeds from the offering (i) to fund the cost of the capped call transactions described below; (ii) to purchase shares of Zoetis' common sto...
12.12.25 - 05:33
Zoetis raises dividend by 6% to $0.53 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.25 - 22:21
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase (Business Wire)
 
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% from the quarterly dividend rate paid in 2025. The dividend will be paid on Tuesday, March 3, 2026, to all holders of record of the Company's common stock as of the close of business on Tuesday, January 20, 2026. About Zoetis As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock producers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in ...
05.12.25 - 02:06
Stocks Hold Steady as Meta Jumps on Deep Metaverse Cuts | The Close 12/4/2025 (Bloomberg)
 
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Vanguard's Roger Hallam, PIMCO's Mohit Mittal, DA Davidson's Michael Baker, Zoetis' Kristin Peck, Moor Insights & Strategy's Patrick Moorhead, BlackRock's Amanda Lynam, MoviePass' Stacy Spikes, Your Rich BFF's Vivian Tu. (Source: Bloomberg)...
05.12.25 - 00:18
Zoetis CEO: Committed to Livestock Category (Bloomberg)
 
Kristen Peck, Zoetis CEO, says the company is committed to livestock, achieving its third consecutive year of above-market growth. She tells Romaine Bostick on “The Close” that Zoetis is focused on breeding healthier animals and providing vaccines and preventatives to keep them well. (Source: Bloomberg)...
04.12.25 - 19:00
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue? (Zacks)
 
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
04.12.25 - 17:31
Zoetis Stock Plummets 24.8% YTD: Here′s What You Need to Know (Zacks)
 
ZTS faces steep YTD losses as safety concerns hit key osteoarthritis therapies, forcing revenue cuts while new approvals aim to stabilize growth....
26.11.25 - 23:21
Zoetis receives European approval for Lenivia for osteoarthritis in dogs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.11.25 - 16:00
Is Zoetis Stock Underperforming the Dow? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 19:12
Tiergesundheits-Aktien: Elanco punktet mit Innovationen, Zoetis kämpft mit Gegenwind (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 11:45
Zoetis: P/E auf Allzeittief (LYNX)
 
Während Investoren verunsichert sind, zeigt ein Blick auf die Fundamentaldaten von Zoetis eine ganz andere Realität. Die Gewinne steigen unaufhörlich....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Soll man zur Beute werden, wieviel besser, / dem Löwen zuzufallen als dem Wolf. - William Shakespeare
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!